Certain information contained in or accessible from this website includes “forward-looking statements” within the meaning of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995.  Forward-looking statements often address our expected future business and financial performance and financial condition, and often contain words such as “believes,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “designed,” “could,” “might,” “will,” “should,” “approximately” or, in each case, their negative or other variations thereon or comparable terminology, although not all forward-looking statements contain these words.  Forward-looking statements are based on information available at the time they were made and should not be relied upon as accurate representations of the Company’s beliefs, expectations, or position after the date they were made.  The Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

The Company’s forward-looking statements are based on assumptions and include inherent risks and uncertainties.  If these risks and uncertainties materialize or if the assumptions underlying forward-looking statements are inaccurate, actual results and developments could materially differ from those expressed in or implied by the Company’s forward-looking statements.

Risks and uncertainties that may impact the Company’s forward-looking statements include, but are not limited to, the timing of and our ability to obtain and maintain U.S. Food and Drug Administration or other regulatory authority approval of, or other action with respect to, our product candidates; the success, timing, and cost of our ongoing or anticipated clinical trials for our current product candidates; the Company’s ability to obtain the capital necessary to fund its operations; the Company’s ability to generate revenues; the successful implementation of the Company’s research and development programs and collaborations; the Company’s ability to commercialize, manufacture, and achieve market acceptance of our product candidates, for which we rely significantly on collaboration with third parties; the Company’s ability to successfully defend its intellectual property or obtain necessary licenses at a cost acceptable to the Company, if at all; the success of the Company’s license agreements; and other factors, including general economic conditions and regulatory developments not within the Company’s control.  A further list and description of the risks and uncertainties that may impact the Company’s forward-looking statements can be found in the Company’s most recently filed Annual Report on Form 10-K, Quarterly Report on Form 10-Q, and the Company’s subsequent filings with the Securities and Exchange Commission.  Copies of these filings are available online at or under the Investor Relations section of this website.